metabolic syndrome
Conditions
Interventions
control group:Chinese medicine simulant
test group:ChaiQi Tang Granules
Sponsors
Dongfang Hospital Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria for metabolic syndrome; (2) Patients whose Chinese medicine diagnosis meets the criteria of spleen deficiency and liver depression; (3) Aged 18-75 years old; (4) Voluntary acceptance of treatment and signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) Serious infections and acute complications within 1 month; (2) Combination of serious primary pathogenic diseases such as severe liver kidney and hematopoietic system; (3) Combined severe cardiovascular and cerebrovascular patients; (4) Pregnant or lactating women or those who are preparing for pregnancy; (5) Persons with mental illness or cognitive impairment; (6) Hypersensitivity or allergy to the components of this preparation; (7) Participating in other clinical trials within 1 month prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin Resistance Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular and cerebrovascular metabolism-related risk factors;Blood rheology and hemodynamic indices;TCM Symptom Score;Inflammation-related cytokines;Indicators of vascular endothelial function;Quality of Survival; | — |
Countries
China
Contacts
Public ContactZhang Liping
Dongfang Hospital Beijing University of Chinese Medicine
Outcome results
None listed